Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
Deferasirox Tablet Market contains market size and forecasts of Deferasirox Tablet in global, including the following market information:
- Global Deferasirox Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Deferasirox Tablet Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Deferasirox Tablet companies in 2021 (%)
The global Deferasirox Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
125mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Deferasirox Tablet include Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Deferasirox Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deferasirox Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Deferasirox Tablet Market Segment Percentages, by Type, 2021 (%)
Global Deferasirox Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Deferasirox Tablet Market Segment Percentages, by Application, 2021 (%)
Global Deferasirox Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Deferasirox Tablet Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Deferasirox Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Deferasirox Tablet revenues share in global market, 2021 (%)
- Key companies Deferasirox Tablet sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Deferasirox Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include: